abstract |
The present invention relates to a compound of formula (I) [Wherein, the substituents A, X 1 , X 2 , X 3 , X 4 and R 5 are as defined in the specification. ] To substituted quinazoline derivatives. Such compounds are suitable for the treatment of disorders or diseases mediated by the activity of PI3K enzymes. |